AIMS: To evaluate studies on the use of positron emission tomography with the glucose analog 18F-fluoro-deoxyglucose (FDG-PET) for the preoperative staging of patients with non-small cell lung cancer (NSCLC) according to the criteria of evidence based medicine and to discuss the cost-effectiveness of the technique. METHODS: Clinical studies published between 1995 and 2002 on the preoperative staging of non-small cell lung cancer were used for this analysis...
Keywords: EbM, nicht kleinzelliges Bronchialkarzinom, Staging, 18 F-FDG-PET, Kosten/Nutzenanalyse
01/2003 | Nuklearmedizin, SchattauerAim: The clinical value of positron emission tomography using fluorine-18 fluoro-deoxy-glucose (FDG-PET) in the staging of adult lymphoma has been shown in many studies...
Keywords: Pädiatrie, Lymphom, Hodgkin, Staging
01/2005 | Nuklearmedizin, SchattauerAim: The incidence of adenocarcinomas of the distal oesophagus (ADE) has dramatically increased in Western countries...
Keywords: FDG PET, Adenokarziom, Ösophagus, Staging
01/2005 | Nuklearmedizin, Schattauer